中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

树突状细胞在慢性乙型肝炎感染中的作用

董加秀 高继君 赵守松

蔡全忠, 王玲山, 孙甲东. 肝胆管结石的类型及术式选择[J]. 临床肝胆病杂志, 1986, 2(4): 204-205.
引用本文: 蔡全忠, 王玲山, 孙甲东. 肝胆管结石的类型及术式选择[J]. 临床肝胆病杂志, 1986, 2(4): 204-205.
Chen XiaoYun, Zhang YongHong, Ma LiNa, Jin Yi, Yu HaiBin, Liu YaLi, Zhang XiaoDan, Guo DanDan, Xu YingXia, Zheng YanHong, Ma Bing, Chen XinYue. Clinical effect of pegylated interferon in combination with ribavirin in the retreatment of previous nonresponders or relapsers of chronic hepatitis C[J]. J Clin Hepatol, 2011, 27(12): 1291-1295.
Citation:

树突状细胞在慢性乙型肝炎感染中的作用

基金项目: 

安徽省教育厅自然科学研究项目(2006KJ105C); 

详细信息
  • 中图分类号: R512.62

Research funding: 

 

  • [1]Hilleman MR.Overview of the pathogenesis, prophylaxis and thera-peusis of viral hepatitis B, with focus on reduction to practical appli-cations[J].Vaccine, 2001, 19∶1837-1848.
    [2]梁晓峰, 陈园生, 王晓军, 等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005, 26∶655-658.
    [3]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2001, 34∶1225-1241.
    [4]Gabrilovich DI, Patterson S, Harvey JJ, et al.Defects in the func-tion of dendrentic cells in murine retroviral infection[J].Adv ExpMed Biol, 1995, 378∶469-472.
    [5]Maria-christina J.Gerd RP.Immunology of hepatitis Binfection[J].Lancet infectious Diseases, 2001, 2∶43-50.
    [6]Kazuhiro K, Luca GG, Yasuhiko K, et al.Natural killer Tcell acti-vation inhibits hepatitis B virus replication in vivo[J].J Exp Med, 2000, 192 (7) ∶921-930.
    [7]Marin AR, Ruiz S, Parrillas V, et al.Origin and differentiation ofdendritic cells[J].Trends Immund, 2001, 22∶691-700.
    [8]Banchereau J, Steinment RM.Dendritic cells and the control of im-munity[J].nature, 1998, 392 (6673) ∶245-252.
    [9]Gomez J, Borras FE, Singh R, et al.Differential up-regulation ofHLA-DM, in varint chain, and CD83 on myeloid and plasmacytoiddendritic cells from peripheral blood[J].Tissue Antigens, 2004, 63 (2) ∶149-157.
    [10]Liu YJ.Dendritic cells subsets and lineagesand their functions ininnate and adaptive immunity[J].Cell, 2001, 106∶259-262.
    [11]Van der Molen RG, Spreagers D, Birda RS, et al.Functional im-pairmentin of myeloid and plasmacytiod dendritic cells of patientswith chronic hepatitis B[J].Hepatology, 2004, 40 (3) ∶738-746.
    [12]李若冰, 陈红松, 费然, 等.慢性乙型肝炎患者外周血树突细胞功能的研究[J].中华医学杂志, 2002, 82 (13) ∶887-890.
    [13]于建武, 王富贵, 吕淑兰.慢性乙型肝炎患者外周血树突细胞功能的研究[J].中华传染病志, 2001, 19 (3) ∶144-147.
    [14]Lohr HF, Pingel S, Bocher WO, et al.Reduced virus specific Thelper cell induction by autologous dendritic cells in patients withchronic hepatitis B-restoration by exogenous interleution-12[J].Clin Exp Immunol, 2002, 130∶107-114.
    [15]刘树人, 张雁.慢性乙型肝炎患者树突状细胞形态、表型和功能的变化[J].细胞与分子免疫学杂志, 2001, 17 (5) ∶437-439.
    [16]Tavakoli S, Schwerin W, Rohwer A, et al.Phenotype and functionof monocyte derived dendritic cells in chronic hepatitis B virus infec-tion[J].J Gen Virol, 2004, 85∶2829-2836.
    [17]Beckebaum S, Cicinnavi VR, Zhang x, et al.Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impairedThelper type-1 respons in vitro:mechanisms for viral immune es-cape[J].Immunology, 2003, 109∶487-495.
    [18]Horrike N, Onji M.The role of dysfunction of dendritic cells inhepatitis B virus persistent infection[J].Nippon Rinsho, 2004, 62Suppl 8∶70-73.
    [19]Kunitani H, Shimizu Y, Murata H, et al.Phenotypic analysis ofcirculating and intrahepatic dendritic cell subsets in patients withshronic liver diseases[J].J Hepatol, 2002, 36∶734-741.
    [20]Chisari FV, Ferrari C.Hepatitis B virus immunopathogenesis[J].Annu Rev Immunol, 1995, 13∶29-60.
    [21]Trippler M, Meyer zum Buschenfelde KH.HBV viral load withinsubpopulations of peripheral blood mononuclear cells in HBV infec-tion using limiting dilution PCR[J].J Virol methods, 1999, 78 (1-2) ∶129-147.
    [22]Munz C, Steinman RM, Fujii S.Dendritic cell maturation by innatelymphocytes:coordinated stimulation of innate and adaptiveimmunity[J].J Exp Med, 2005, 202∶203-207.
    [23]Akbar SM, Masumoto T.Mechanism of action of vaccine therapy inmurine hepatitis B virus carriers:vaccine induced activation of anti-gen presenting dendritic cells[J].J Hepatol, 1999, 30∶755-764.
    [24]Morikazu Onji.Dendritic cells in clinics[M].Tokyo, Japan:Springer, 2004∶9-40.
    [25]Horiike N, Akbar SMF, Ninomiya T, et al.Activition and matura-tion of antigen-presenting dendritic cells during vaccine therapy inpatients with chronic hepatitis due to hepatitis B virus[J].HepatolRes, 2002, 23∶38-47.
    [26]刑利和, 马文平, 王友臣, 等.HBsAg致敏的树突状细胞体外抗乙型肝炎病毒的效应[J].解放军医学杂志, 2007, 32∶39-42.
    [27]Oka Y, Akbar SM, Horiike N, et al.Mechanism and therapeuticpotential of DNA-based immunization against the envelope proteinsof hepatitis B virus in normal and transgenic mice[J].Immunology, 2001, 103∶90-97.
  • 加载中
计量
  • 文章访问数:  2096
  • HTML全文浏览量:  12
  • PDF下载量:  1086
  • 被引次数: 0
出版历程
  • 出版日期:  2008-04-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回